Eurofins Scient (OTCMKTS:ERFSF) Stock Price Down 4.1% – Here’s Why
by Tristan Rich · The Markets DailyEurofins Scient (OTCMKTS:ERFSF – Get Free Report) was down 4.1% on Monday . The stock traded as low as $70.7480 and last traded at $71.1760. Approximately 756 shares traded hands during trading, a decline of 49% from the average daily volume of 1,496 shares. The stock had previously closed at $74.21.
Analyst Upgrades and Downgrades
A number of analysts recently commented on ERFSF shares. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Eurofins Scient in a research report on Wednesday, October 29th. Citigroup restated a “neutral” rating on shares of Eurofins Scient in a research note on Wednesday, October 22nd. One analyst has rated the stock with a Strong Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold”.
Check Out Our Latest Report on Eurofins Scient
Eurofins Scient Trading Up 3.1%
The company has a 50-day moving average of $69.97 and a two-hundred day moving average of $72.65. The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77.
Eurofins Scient Company Profile
Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.
Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.